EPIGRAL

Epigral Share PriceEpigral

₹906.6
1.55 (0.17%)
As on 02 December, 2023 | 23:48 BSE: 543332 NSE: EPIGRALISIN: INE071N01016

Epigral Performance

Day Range

  • Low 902.05
  • High 921.95
₹ 906.6

52 Week Range

  • Low 815.00
  • High 1,292.15
₹ 906.6
  • Open Price906.00
  • Previous Close905.05
  • Volume43554

Start SIP in Epigral

Start SIP

Epigral Share Price

  • Over 1 Month 1.03%
  • Over 3 Month -9.69%
  • Over 6 Month -2.85%
  • Over 1 Year -27.75%

Epigral Key Statistics

P/E Ratio 16.9
PEG Ratio -0.4
Market Cap Cr 3,767
Price to Book Ratio 3.5
EPS 85
Dividend 0.6
Relative Strength Index 43.84
Money Flow Index 62.47
MACD Signal -8.84
Average True Range 22.05

Epigral Investment Rating

  • Master Rating:
  • Epigral Ltd has an operating revenue of Rs. 2,033.06 Cr. on a trailing 12-month basis. An annual revenue growth of 41% is outstanding, Pre-tax margin of 24% is great, ROE of 33% is exceptional. The company has a reasonable debt to equity of 41%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. It is currently FORMING a base in its weekly chart and is trading around 23% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 56 which is a POOR score indicating inconsistency in earnings, a RS Rating of 10 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B which is evident from recent demand for the stock, Group Rank of 152 indicates it belongs to a poor industry group of Chemicals-Specialty and a Master Score of D is close to being the worst. Institutional holding has remained stable in the last reported quarter. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Epigral Financials
IndicatorSep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 478455562538556533499
Operating Expenses Qtr Cr 370360407371375345324
Operating Profit Qtr Cr 10895155167180187175
Depreciation Qtr Cr 32313031262221
Interest Qtr Cr 21181921141112
Tax Qtr Cr 18163337504945
Net Profit Qtr Cr 383277779210899
IndicatorMar 2023Mar 2022
Total Revenue Annual Cr 2,1961,555
Operating Expenses Annual Cr 1,4991,041
Operating Profit Annual in Cr 689509
Depreciation Cr 10986
Interest Annual Cr 6644
Tax Annual Cr 169131
Net Profit Annual Cr 353253
IndicatorMar 2023Mar 2022
Cash from Operating Activity Annual Cr 626284
Cash from Investing Activity Annual Cr -437-455
Cash from Financing Annual Activity Cr -200195
Net Cash Flow Annual Cr -1124
IndicatorMar 2023Mar 2022
Total ShareHolders Funds Annual Cr 1,179726
Fixed Assets Annual Cr 1,9621,657
Total Non Current Assets Annual Cr 2,0131,677
Total Current Assets Annual Cr 419447
Total Assets Annual Cr 2,4322,124
IndicatorMar 2023Mar 2022
Book Value Per Share Annual Rs 257175
ROE Annual % 3335
ROCE Annual % 3327
Total Debt to Total Equity Annual --
EBDIT Annual Margin % 3233
IndicatorSep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 478455562538556533499
Operating Expenses Qtr Cr 370360408371375345324
Operating Profit Qtr Cr 10895155167180187175
Depreciation Qtr Cr 32313031262221
Interest Qtr Cr 21181921141112
Tax Qtr Cr 18163337504945
Net Profit Qtr Cr 383277779210899
IndicatorMar 2023Mar 2022
Total Revenue Annual Cr 2,1961,555
Operating Expenses Annual Cr 1,4991,041
Operating Profit Annual in Cr 689509
Depreciation Cr 10986
Interest Annual Cr 6644
Tax Annual Cr 169131
Net Profit Annual Cr 353253
IndicatorMar 2023Mar 2022
Cash from Operating Activity Annual Cr 626284
Cash from Investing Activity Annual Cr -437-455
Cash from Financing Annual Activity Cr -200195
Net Cash Flow Annual Cr -1124
IndicatorMar 2023Mar 2022
Total ShareHolders Funds Annual Cr 1,179726
Fixed Assets Annual Cr 1,9621,657
Total Non Current Assets Annual Cr 2,0131,677
Total Current Assets Annual Cr 419447
Total Assets Annual Cr 2,4322,124
IndicatorMar 2023Mar 2022
Book Value Per Share Annual Rs 257175
ROE Annual % 3335
ROCE Annual % 3327
Total Debt to Total Equity Annual --
EBDIT Annual Margin % 3233

Epigral Technicals

EMA & SMA

Current Price
₹906.6
1.55 (0.17%)
pointer
  • Bullish Moving Average
  • ___
  • 0
  • Bearish Moving Average
  • ___
  • 16
  • 20 Day
  • ₹915.72
  • 50 Day
  • ₹933.58
  • 100 Day
  • ₹955.79
  • 200 Day
  • ₹997.33
  • 20 Day
  • ₹914.07
  • 50 Day
  • ₹940.18
  • 100 Day
  • ₹952.18
  • 200 Day
  • ₹974.47

Epigral Resistance and Support

PIVOT
₹910.2
Resistance
First Resistance 918.35
Second Resistance 930.10
Third Resistance 938.25
RSI 43.84
MFI 62.47
MACD Single Line -8.84
MACD -7.14
Support
First Resistance 898.45
Second Resistance 890.30
Third Resistance 878.55

Epigral Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 50,452 2,976,668 59
Week 37,767 1,983,119 52.51
1 Month 32,278 1,646,836 51.02
6 Month 97,510 3,195,408 32.77

Epigral Result Highlights

Epigral Synopsis

NSE-Chemicals-Specialty

Epigral Ltd is involved in the business activities of Manufacture of organic and inorganic chemical compounds. Company’s Total Operating Revenue is Rs. 2188.40 Cr. and Equity Capital is Rs. 41.55 Cr. for the Year ended 31/03/2023. Meghmani Finechem Ltd. is a Public Limited Listed company incorporated on 11/09/2007 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is L24100GJ2007PLC051717 and registration number is 051717.
Market Cap 3,767
Sales 2,033
Shares in Float 1.20
No of funds 58
Yield 0.55
Book Value 3.52
U/D Vol ratio 0.9
LTDebt / Equity 41
Alpha -0.15
Beta 0.98

Epigral

Owner NameSep-23Jun-23Mar-23Dec-22
Promoters 71.38%71.37%71.34%71.21%
Mutual Funds 0.04%0.04%0.03%
Foreign Portfolio Investors 1.14%1.16%1.2%1.15%
Individual Investors 21.05%21.22%21.13%21.43%
Others 6.39%6.21%6.3%6.21%

Epigral Management

Name Designation
Mr. Maulik Jayantibhai Patel Chairman & Managing Director
Mr. Kaushal Ashish Soparkar Executive Director
Mr. Ankit Natwarlal Patel Non Executive Director
Mr. Karana Rameshbhai Patel Non Executive Director
Mr. Darshan Anandbhai Patel Non Executive Director
Mr. Manubhai Patel Independent Director
Mr. Sanjay Asher Independent Director
Mr. Kanubhai Shakarabhai Patel Independent Director
Mr. Raju Swamy Independent Director
Ms. Nirali Parikh Independent Director

Epigral Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Epigral Corporate Action

Date Purpose Remarks
2023-11-06 Quarterly Results
2023-08-05 Quarterly Results
2023-04-25 Audited Results & Final Dividend
2023-01-19 Quarterly Results & Interim Dividend
2022-10-20 Quarterly Results
Date Purpose Remarks
2023-06-20 FINAL Rs.2.50 per share(25%)Final Dividend
2023-02-01 INTERIM Rs.2.50 per share(25%)Interim Dividend

Epigral MF Shareholding

Name Amount(cr)
Nippon India Nifty Smallcap 250 Index Fund Reg Gr 719
Motilal Oswal Nifty 500 Fund Regular Growth 548
Motilal Oswal Nifty Smallcap 250 Index Fund Regular Growth 453
SBI Nifty Smallcap 250 Index Fund Regular Growth 332
ICICI Prudential Nifty Smallcap 250 Index Fund Regular Growth 183

Epigral FAQs

What is Share Price of Epigral ?

Epigral share price is ₹906 As on 02 December, 2023 | 23:34

What is the Market Cap of Epigral ?

The Market Cap of Epigral is ₹3766.9 Cr As on 02 December, 2023 | 23:34

What is the P/E ratio of Epigral ?

The P/E ratio of Epigral is 16.9 As on 02 December, 2023 | 23:34

What is the PB ratio of Epigral ?

The PB ratio of Epigral is 3.5 As on 02 December, 2023 | 23:34

Q2FY23